CVE:KSI

kneat.com Stock Forecast, Price & News

C$3.08

-0.04 (-1.28 %)

(As of 08/4/2021 02:00 PM ET)

Add

Compare

Today's Range

C$3.01

▼

C$3.08

50-Day Range

C$2.81

▼

C$3.12

52-Week Range

C$1.89

▼

C$3.45

Volume2,726 shs

Average Volume50,043 shs

Market CapitalizationC$235.65 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive KSI News and Ratings via Email

Sign-up to receive the latest news and ratings for kneat.com and its competitors with MarketBeat's FREE daily newsletter.

About kneat.com

kneat.com, inc. designs, develops, and supplies software for data and document management within regulated environments in the United States, Ireland, Canada, internationally. The company offers Kneat Gx platform, a configurable commercial off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries. Its platform is used in instrument, method, utility and facility, process, equipment, computer system, cold chain, and cleaning validation, as well commissioning and qualification, and electronic logbook management. It also provides software-related services, including training, installation, upgradation, consulting, and maintenance, as well as process mapping, project management, and other services. The company is headquartered in Limerick, Ireland.

Leading Global Healthcare Brand Selects Kneat's SaaS Platform
July 19, 2021 | finance.yahoo.com

Investors Who Bought kneat.com (CVE:KSI) Shares Three Years Ago Are Now Up 214%
May 29, 2021 | ca.finance.yahoo.com

Kneat Reports 2021 First Quarter Results
May 25, 2021 | markets.businessinsider.com

Kneat Announces New Director, New Omnibus Plan, and Release Date Q1 Results
May 21, 2021 | markets.businessinsider.com

Kneat Announces Closing of $20,125,575 Public Equity Financing and Concurrent $2,000,000 Non-Brokered Private Placement Equity Financing
April 28, 2021 | ca.finance.yahoo.com

Kneat Announces $17.5 Million Bought Deal Public Offering
April 7, 2021 | ca.finance.yahoo.com

kneat.com, inc. (FOBK.F)
March 19, 2021 | ca.finance.yahoo.com

kneat.com Inc. Registered Share (FOBK.SG)
March 19, 2021 | ca.finance.yahoo.com

Lewandowski overtakes Raul as Champions League's third-highest scorer with only Ronaldo and Messi ahead
February 23, 2021 | msn.com

Kneat Announces Fiscal 2020 Fourth Quarter and Fiscal Year 2020 Results
February 23, 2021 | markets.businessinsider.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange CVE
Industry Health Information Services
Sub-IndustryN/A
SectorMedical
Current SymbolCVE:KSI
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.kneat.com
Phone353 6 120 3826
Employees60
Year FoundedN/A

Sales & Book Value

Annual SalesC$8.82 million
Price / Sales26.71
Cash FlowC$0.09 per share
Price / Cash Flow34.22
Book ValueC$0.26 per share
Price / Book11.94

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares76,510,000
Market CapC$235.65 million
Next Earnings Date8/25/2021 (Estimated)
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

1.55 out of 5 stars

3.5 Analyst's Opinion

Consensus Rating
kneat.com has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of C$4.50, kneat.com has a forecasted upside of 46.1% from its current price of C$3.08.
Amount of Analyst Coverage
kneat.com has received no research coverage in the past 90 days.

4.3 Community Rank

Outperform Votes
kneat.com has received 20 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
kneat.com has received 11 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
kneat.com has received 64.52% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about kneat.com and other stocks. Vote “Outperform” if you believe KSI will outperform the S&P 500 over the long term. Vote “Underperform” if you believe KSI will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
kneat.com does not currently pay a dividend.
Dividend Growth
kneat.com does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, kneat.com insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of kneat.com is -22.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of kneat.com is -22.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
kneat.com has a P/B Ratio of 11.94. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

kneat.com (CVE:KSI) Frequently Asked Questions

Is kneat.com a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for kneat.com in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" kneat.com stock.
View analyst ratings for kneat.com or view top-rated stocks.

What stocks does MarketBeat like better than kneat.com?

Wall Street analysts have given kneat.com a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but kneat.com wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is kneat.com's next earnings date?

kneat.com is scheduled to release its next quarterly earnings announcement on Wednesday, August 25th 2021.
View our earnings forecast for kneat.com.

How were kneat.com's earnings last quarter?

kneat.com, inc. (CVE:KSI) posted its quarterly earnings data on Tuesday, May, 25th. The company reported ($0.06) earnings per share for the quarter. The company had revenue of $2.36 million for the quarter, compared to analyst estimates of $2.40 million.
View kneat.com's earnings history.

How has kneat.com's stock price been impacted by COVID-19 (Coronavirus)?

kneat.com's stock was trading at C$1.93 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, KSI stock has increased by 59.6% and is now trading at C$3.08.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for KSI?

1 brokerages have issued twelve-month price objectives for kneat.com's stock. Their forecasts range from C$4.50 to C$4.50. On average, they expect kneat.com's stock price to reach C$4.50 in the next twelve months. This suggests a possible upside of 46.1% from the stock's current price.
View analysts' price targets for kneat.com or view top-rated stocks among Wall Street analysts.

Who are kneat.com's key executives?

kneat.com's management team includes the following people:

Mr. Edmund Ryan, Co-Founder, CEO, Pres, Sales Director & Exec. Director (Age 57, Pay $234.52k)
Mr. Brian Ahearne, Co-Founder, Chief Information Officer & Company Sec. (Age 52, Pay $210.16k)
Mr. Kevin Fitzgerald, Co-founder, Chief Product Officer & Exec. Director (Age 51, Pay $210.16k)
Mr. Hugh Kavanagh, Chief Financial Officer (Age 59, Pay $209.53k)
Mr. Keith Holmes, Chief Technology Officer
Ms. Laura Sweet, VP of Marketing

Who are some of kneat.com's key competitors?

Some companies that are related to kneat.com include Craneware (CRW), CloudMD Software & Services (DOC), Forian (FORA), Sensyne Health (SENS), Reliq Health Technologies (RHT), Vitalhub (VHI), Induction Healthcare Group (INHC), DIAGNOS (ADK), IQ-AI (IQAI), CardioComm Solutions (EKG), ZoomMed (ZMD), 1st Group (1ST), Alcidion Group (ALC), Binovi Technologies (BNVIF) and Cann American (CNNA).
View all of KSI's competitors.

What other stocks do shareholders of kneat.com own?

Based on aggregate information from My MarketBeat watchlists, some companies that other kneat.com investors own include Brookfield Property Partners (BPY.UN), Eldorado Gold (ELD), NVIDIA (NVDA), Yamana Gold (YRI), Aurora Cannabis (ACB), The Boeing (BA), Intercontinental Exchange (ICE), Lightspeed POS (LSPD), Palo Alto Networks (PANW) and Polo Resources (POL).

What is kneat.com's stock symbol?

kneat.com trades on the Canadian Venture Exchange (CVE) under the ticker symbol "KSI."

How do I buy shares of kneat.com?

Shares of KSI and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is kneat.com's stock price today?

One share of KSI stock can currently be purchased for approximately C$3.08.

How much money does kneat.com make?

kneat.com has a market capitalization of C$235.65 million and generates C$8.82 million in revenue each year.

How many employees does kneat.com have?

kneat.com employs 60 workers across the globe.

What is kneat.com's official website?

The official website for kneat.com is www.kneat.com.

How can I contact kneat.com?

The company can be reached via phone at 353 6 120 3826.

This page was last updated on 8/4/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here